Peng Wang

Dr. Peng Wang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2025 in ACS Sensors
Verified
Journal Article
Closed access
GMGuo-Jiang Mao
Guo-Jiang Mao
TYTian-Tian Yang
Tian-Tian Yang
YGYijun Gong
Yijun Gong
NMNana Ma
Nana Ma
PWPeng Wang
Peng Wang
GZGuisheng Zhang
Guisheng Zhang

8 May 2017 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
EDEnming Du
Enming Du
XHXunwu Hu
Xunwu Hu
SRSona Roy
Sona Roy
PWPeng Wang
Peng Wang
KDKieran Deasy
Kieran Deasy
YZYe Zhang
Ye Zhang
Symmetrical taurine modification not only enhances the intracellular affinity of a polypyridyl Ru-complex to cancer cells, but also boosts the quantum yield in a pH-independent manner without sacrificing water solubility for cytosolic photosensitizers of photodynamic therapy, with prominent efficacy in cancerous brain cells.

5 December 2024 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
HLHengxuan Li
Hengxuan Li
XFXiaoyi Fu
Xiaoyi Fu
QYQimin You
Qimin You
DSDawei Shi
Dawei Shi
LSLingxuan Su
Lingxuan Su
WTWeihong Tan
Weihong Tan
Respiratory infectious diseases spread rapidly and have a wide range of impacts, posing a serious threat to public health security. The development of a sensitive, accurate, and rapid detection method for respiratory viruses is crucial for disease prevention and control. However, existing methods are inadequate in satisfying the demand for accurate and convenient detection simultaneously. Therefore, an ultrasensitive point-of-care testing (POCT) platform based on a multiple aptamer recognition-based quantum dot lateral flow immunoassay (MARQ-LFIA) was developed in this work. This platform consisted of multiple high-affinity aptamers for recognizing different sites on a respiratory infectious virus protein, enhancing the efficiency of virus identification in complex environments. By combining a multiple aptamer recognition strategy with quantum dot fluorescent technique to construct LFIA test strips and pairing them with a high-gain portable fluorescence reader, excellent detection sensitivity and specificity were achieved in the case of coronavirus disease 2019 (COVID-19). The limits of detection were 1.427 pg mL−1 and 1643 U mL−1 towards the nucleocapsid protein and inactivated viruses, respectively, indicating that MARQ-LFIA improved detection sensitivity compared to reported methods. More critically, by testing thirty COVID-19 positive and twenty negative patient samples, the positive detection rate increased from 55.17% to 86.67% compared with commercially similar products. The universality of MARQ-LFIA was also investigated for diagnosing influenza B. We believe that MARQ-LFIA can be a promising POCT tool with potential applications in the areas of public health for the growing demand for precision diagnosis and treatment.

17 October 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
HLHengxuan Li
Hengxuan Li
XMXiangqi Ma
Xiangqi Ma
DSDawei Shi
Dawei Shi
PWPeng Wang
Peng Wang
The precise analysis of protein interactions in their native cellular context and the sensitive quantification of protein abundance in biological fluids are both fundamental to understanding health and disease. Traditional methods for cellular imaging and biochemical quantification often face limitations in specificity, sensitivity, or the preservation of spatial information. The proximity ligation assay (PLA) is a versatile technological platform developed to overcome these challenges by converting protein recognition events into amplifiable DNA signals, thereby achieving exceptional sensitivity. This foundational principle has given rise to two major formats: in situ PLA (isPLA) and solution-phase PLA. In basic research, isPLA provides high-resolution visualization of protein–protein interactions (PPIs), post-translational modifications (PTMs), and subcellular architecture directly within fixed cells and tissues. In translational and clinical applications, solution-phase PLA enables the highly sensitive quantification of low-abundance biomarkers in liquid samples, which is critical for diagnostics and prognostics in fields such as oncology, neuroscience, and infectious diseases. This review discusses the foundational principles, development, and diverse applications of PLA platforms. We also highlight significant technological advancements, including the development of high-throughput formats, integration with advanced readouts, and the use of alternative affinity reagents. These innovations continue to transform PLA from a targeted validation method into a powerful and multifaceted platform for both fundamental systems biology and clinical diagnostics.

2 September 2022 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
PWPeng Wang
Peng Wang
MLMili Li
Mili Li
FZFang Zhou
Fang Zhou
YYYue Yang
Yue Yang
XYXia Yin
Xia Yin
GSGuosheng Song
Guosheng Song
Herein, we report a new click-activated prodrug, CA4V, and a bioorthogonal nanoreactor, CA4V/ZIF-90@TzCOF@Apt, which consists of a ZIF-90 core, tetrazine-based covalent organic framework (COF) shells and an aptamer polymer coating. When targeting a tumor, the acid-causing collapse of ZIF-90 initiates a nanoconfined bioorthogonal reaction in defined COF cages, which boosts the click efficiency of CA4V activation and therapeutic effects in vivo.

22 February 2014 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
CSChunlong Sun
Chunlong Sun
YWYang Wu
Yang Wu
JCJin Cai
Jin Cai
PWPeng Wang
Peng Wang
XZXi Zong
Xi Zong
MJMin Ji
Min Ji